Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Dec 22, 2009

Premium

Edward Erickson has been elected as president and CEO of BioNanomatrix by the company's board of directors. Erickson, who was executive chairman of the board, succeeds Michael Boyce-Jacino, who has stepped down as president and CEO and from the board. Tracy Warren, a general partner at Battelle Ventures, an investor in BioNanomatrix, will become chair of the board.

Most recently, Erickson was a consultant to companies and venture capital firms. In the past, he was president, CEO, or a director of more than a dozen life-science-based companies, several of which completed IPOs under his leadership. He is currently a director at Metabolon and at Molecular Biometrics. Erickson holds an MBA in general management from Harvard Business School and MS and BS degrees in mathematics from the Illinois Institute of Technology.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.